Serum PTTG3P was demonstrated to obtain a fine diagnostic accuracy in distinguishing HCC from LC patients, CHB patients, and healthy controls while the diagnostic potential of serum PTENP1 seems unsatisfactory. This evidence concerns the gene PTENP1 and laryngotracheoesophageal cleft.